Capstar Special Purpose Acquisition Corp.

Capstar Special Purpose Acquisition Corp. is a blank-check company (SPAC) that raised $240M in its initial public offering on Jul 6, 2020, listing on New York Stock Exchange. It completed its business combination with Gelesis, Inc. on Jan 13, 2022; the combined company is Gelesis Holdings, Inc. (GLS). Greenberg Traurig advised the SPAC and Kirkland & Ellis advised the underwriters on the IPO.

Gelesis is a consumer-centered biotherapeutics company advancing a novel category of treatments for weight management and gut-related chronic diseases. It is the target of a proposed business combination with Capstar, a special purpose acquisition company.

Status

Merger completed

IPO date

Jul 6, 2020

IPO size

$240M

IPO exchange

New York Stock Exchange

Target

Gelesis, Inc.

Announced

Jul 19, 2021

Closed

Jan 13, 2022

Combined company

Gelesis Holdings, Inc. (GLS)

SPAC counsel (IPO)

Greenberg Traurig

Underwriters' counsel (IPO)

Kirkland & Ellis